Formosanin-C, an immunomodulator with antitumor activity

Area of Science:

• Immunology
• Pharmacology
• Natural Products Chemistry

Background:

• Paris formosana Hayata, a plant used in traditional medicine, contains compounds with potential therapeutic properties.
• Formosanin-C is a diosgenin saponin isolated from Paris formosana.
• Its effects on the immune system and anti-tumor activity warrant investigation.

Purpose of the Study:

• To investigate the immunomodulatory effects of formosanin-C.
• To evaluate the anti-tumor activity of formosanin-C against transplantable murine tumors.
• To explore the potential of formosanin-C as an anti-cancer agent.

Main Methods:

• In vitro studies using human peripheral blood cells and ConA-stimulated lymphocytes to assess blastogenesis and thymidine incorporation.
• In vitro assessment of granulocyte/macrophage colony-forming cells (GM-CFC) responsiveness.
• In vivo studies involving intraperitoneal administration of formosanin-C in mice to evaluate natural killer cell activity, interferon production, and anti-tumor effects against MH134 hepatoma.

Main Results:

• Formosanin-C significantly enhanced the blastogenic response of human peripheral blood cells to phytohemagglutinin and increased thymidine incorporation in ConA-stimulated lymphocytes.
• It altered the responsiveness of GM-CFC and activated natural killer cell activity in mice.
• Formosanin-C induced interferon production and retarded the growth of MH134 mouse hepatoma, also potentiating the activity of 5-fluorouracil.

Conclusions:

• Formosanin-C exhibits significant immunomodulatory effects, enhancing cellular immune responses.
• The compound demonstrates direct anti-tumor activity against murine hepatoma and can potentiate chemotherapy.
• These findings suggest that formosanin-C holds promise as an anti-cancer therapeutic agent, potentially through immune system modulation.